A New Horizon in Asthma: Inhibiting ILC Function

Article Tools

• Email

  Thank you for your interest in spreading the word about Science Translational Medicine.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following A New Horizon in Asthma: Inhibiting ILC Function

  Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

  Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

  Your Personal Message

  Send Message
• Download Powerpoint
• Print
• Save to my folders

  Log In with your AAAS Login

   

• Alerts

  Please log in to add an alert for this article.

  Log In with your AAAS Login

   

  Sign In to Email Alerts with your Email Address

  Email

  Log in
• Citation tools

  A New Horizon in Asthma: Inhibiting ILC Function

  By R. Stokes Peebles, Jr.

  Science Translational Medicine27 Feb 2013 : 174fs7

  Innate lymphoid cells (ILCs) produce cytokines that drive allergic responses in asthma and can be inhibited by lipoxin A₄ (Barnig et al., this issue).

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  A New Horizon in Asthma: Inhibiting ILC Function

  By R. Stokes Peebles, Jr.

  Science Translational Medicine27 Feb 2013 : 174fs7

  Innate lymphoid cells (ILCs) produce cytokines that drive allergic responses in asthma and can be inhibited by lipoxin A₄ (Barnig et al., this issue).

  Share This Article: Copy